A new UK education programme aimed at multiple sclerosis specialist nurses has been launched by pharmaceutical company Sanofi Genzyme.
It said its OptiMiSe programme was intended to support patient-centred care and changes in clinical practice for improved patient outcomes.
The company noted that specialist nurses who care for people with the long-term condition must be “highly skilled, up-to-date on MS care developments and able to navigate a resource-constrained NHS”.
Developed by a nurse-led steering committee, it said OptiMiSe will be carried out through face-to-face meetings as well as a web-based platform.
The programme supports nurses in providing the highest-quality care to people affected by MS, as well as in the leading and managing of efficient service delivery, said Sanofi.
The course has already been piloted successfully through Sanofi’s Royal College of Nursing accredited courses in London and York, the company added.
Nicki Abel, chair of the expert steering committee and MS specialist nurse at the Queen Elizabeth Hospital Birmingham, said: “The programme is rooted in a unique combination of skills transfer, knowledge-share and thinking to tackle some of the barriers MS nurses face in their daily practice.
“The way in which we approached the programme and are conducting the training makes it fundamentally different from other education programmes, as it is structured around each nurse’s personal objectives, which encourages active participation, autonomous learning and passion for driving change and the process of learning,” she said.
For information, contact: email@example.com